TWO SIGMA INVESTMENTS, LP - HARVARD BIOSCIENCE INC ownership

HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 77 filers reported holding HARVARD BIOSCIENCE INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of HARVARD BIOSCIENCE INC
ValueSharesWeighting
Q2 2024$168,788
-5.2%
59,224
+41.1%
0.00%
Q1 2024$177,999
-37.5%
41,981
-21.1%
0.00%
-100.0%
Q4 2023$284,829
-49.4%
53,239
-59.4%
0.00%
-50.0%
Q3 2023$563,390
-14.6%
131,021
+9.1%
0.00%0.0%
Q2 2023$659,481
+128.9%
120,124
+75.1%
0.00%
+100.0%
Q1 2023$288,061
-19.9%
68,586
-47.2%
0.00%0.0%
Q4 2022$359,662
-18.8%
129,842
-25.0%
0.00%
-50.0%
Q3 2022$443,000
+23.7%
173,118
+73.9%
0.00%
+100.0%
Q2 2022$358,000
+9.5%
99,523
+88.9%
0.00%0.0%
Q1 2022$327,000
-66.1%
52,688
-61.6%
0.00%
-50.0%
Q4 2021$966,000
-36.0%
137,061
-36.6%
0.00%
-33.3%
Q3 2021$1,509,000
-30.3%
216,144
-16.9%
0.00%
-40.0%
Q2 2021$2,166,000
+185.8%
260,084
+87.2%
0.01%
+150.0%
Q1 2021$758,000
+76.7%
138,919
+38.9%
0.00%
+100.0%
Q4 2020$429,000
+158.4%
99,983
+81.7%
0.00%0.0%
Q3 2020$166,000
+5.1%
55,014
+8.1%
0.00%0.0%
Q2 2020$158,000
+1.9%
50,914
-27.4%
0.00%0.0%
Q1 2020$155,000
-70.3%
70,115
-59.0%
0.00%
-50.0%
Q4 2019$522,000
-36.7%
171,107
-36.2%
0.00%
-33.3%
Q3 2019$824,000
+72.4%
268,086
+12.2%
0.00%
+50.0%
Q2 2019$478,000
+123.4%
238,952
+380.3%
0.00%
+100.0%
Q1 2019$214,000
-19.2%
49,747
-40.3%
0.00%0.0%
Q4 2018$265,000
-61.9%
83,302
-37.1%
0.00%
-50.0%
Q3 2018$696,000
+2477.8%
132,530
+1173.8%
0.00%
Q2 2017$27,000
-3.6%
10,404
-2.8%
0.00%
Q1 2017$28,000
-15.2%
10,704
-0.9%
0.00%
Q4 2016$33,000
+10.0%
10,804
-0.9%
0.00%
Q3 2016$30,000
-3.2%
10,904
-0.9%
0.00%
Q2 2016$31,000
-16.2%
11,004
-11.3%
0.00%
Q1 2016$37,000
-77.2%
12,404
-73.5%
0.00%
-100.0%
Q4 2015$162,000
+326.3%
46,821
+364.8%
0.00%
Q3 2015$38,000
-64.5%
10,073
-46.3%
0.00%
Q2 2015$107,000
-30.5%
18,741
-29.4%
0.00%
-100.0%
Q1 2015$154,000
+2.7%
26,5410.0%0.00%0.0%
Q4 2014$150,000
-1.3%
26,541
-28.6%
0.00%0.0%
Q3 2014$152,000
-53.1%
37,197
-47.8%
0.00%0.0%
Q2 2014$324,000
+191.9%
71,196
+203.7%
0.00%0.0%
Q1 2014$111,000
+38.8%
23,445
+53.2%
0.00%0.0%
Q3 2013$80,000
+8.1%
15,300
-1.9%
0.00%0.0%
Q2 2013$74,00015,5900.00%
Other shareholders
HARVARD BIOSCIENCE INC shareholders Q4 2013
NameSharesValueWeighting ↓
AMH Equity Ltd 2,199,922$6,269,7788.31%
272 Capital LP 1,535,820$4,377,0872.19%
Meros Investment Management, LP 835,213$2,380,3571.13%
Harvey Partners, LLC 2,557,500$7,288,8750.88%
Acuitas Investments, LLC 407,343$1,160,9280.62%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 2,772,339$7,901,1660.46%
BARD ASSOCIATES INC 296,995$846,4360.32%
Riverwater Partners LLC 105,977$302,0340.22%
Granahan Investment Management 1,925,398$5,487,3840.22%
HEARTLAND ADVISORS INC 1,200,000$3,420,0000.19%
View complete list of HARVARD BIOSCIENCE INC shareholders